These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24133297)

  • 21. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
    J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GS-9620 inhibits enterovirus 71 replication mainly through the NF-κB and PI3K-AKT signaling pathways.
    Zhang Q; Zhao B; Chen X; Song N; Wu J; Li G; Yu P; Han Y; Liu J; Qin C
    Antiviral Res; 2018 May; 153():39-48. PubMed ID: 29425831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The innate immune response, clinical outcomes, and ex vivo HCV antiviral efficacy of a TLR7 agonist (PF-4878691).
    Fidock MD; Souberbielle BE; Laxton C; Rawal J; Delpuech-Adams O; Corey TP; Colman P; Kumar V; Cheng JB; Wright K; Srinivasan S; Rana K; Craig C; Horscroft N; Perros M; Westby M; Webster R; van der Ryst E
    Clin Pharmacol Ther; 2011 Jun; 89(6):821-9. PubMed ID: 21451504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 7 agonist induces hypoplasia of the biliary system in a neonatal mouse model.
    Huang YH; Shih HH; Tiao MM; Huang CC; Kuo KC; Huang FC; Yang YL; Chuang JH
    J Microbiol Immunol Infect; 2018 Apr; 51(2):166-173. PubMed ID: 27590984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro-generated viral double-stranded RNA in contrast to polyinosinic:polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells.
    Löseke S; Grage-Griebenow E; Heine H; Wagner A; Akira S; Bauer S; Bufe A
    Scand J Immunol; 2006 Apr; 63(4):264-74. PubMed ID: 16623926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TLR7 is a key regulator of innate immunity against Japanese encephalitis virus infection.
    Nazmi A; Mukherjee S; Kundu K; Dutta K; Mahadevan A; Shankar SK; Basu A
    Neurobiol Dis; 2014 Sep; 69():235-47. PubMed ID: 24909816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
    Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
    Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
    Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance.
    Bourquin C; Hotz C; Noerenberg D; Voelkl A; Heidegger S; Roetzer LC; Storch B; Sandholzer N; Wurzenberger C; Anz D; Endres S
    Cancer Res; 2011 Aug; 71(15):5123-33. PubMed ID: 21697281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9.
    Hoshino K; Sugiyama T; Matsumoto M; Tanaka T; Saito M; Hemmi H; Ohara O; Akira S; Kaisho T
    Nature; 2006 Apr; 440(7086):949-53. PubMed ID: 16612387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults.
    Pierson W; Tuefferd M; Herschke F; Slaets L; Crabbe M; Verstappen D; De Pelsmaeker S; Strickland I; Gane EJ; Schwabe C; Zhang Y; Meerts P; Vandenbossche J; Van Remoortere P; Verbrugge I; De Creus A
    Antivir Ther; 2023 Jun; 28(3):13596535231172878. PubMed ID: 37199270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-alpha fusion protein in cynomolgus monkeys.
    Osborn BL; Olsen HS; Nardelli B; Murray JH; Zhou JX; Garcia A; Moody G; Zaritskaya LS; Sung C
    J Pharmacol Exp Ther; 2002 Nov; 303(2):540-8. PubMed ID: 12388634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic-pharmacodynamic modeling of alpha interferon response induced by a Toll-like 7 receptor agonist in mice.
    Benson N; de Jongh J; Duckworth JD; Jones HM; Pertinez HE; Rawal JK; van Steeg TJ; Van der Graaf PH
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1179-85. PubMed ID: 20028817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463.
    Wagner TL; Horton VL; Carlson GL; Myhre PE; Gibson SJ; Imbertson LM; Tomai MA
    Cytokine; 1997 Nov; 9(11):837-45. PubMed ID: 9367544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR7 agonist 852A inhibition of tumor cell proliferation is dependent on plasmacytoid dendritic cells and type I IFN.
    Inglefield JR; Dumitru CD; Alkan SS; Gibson SJ; Lipson KE; Tomai MA; Larson CJ; Vasilakos JP
    J Interferon Cytokine Res; 2008 Apr; 28(4):253-63. PubMed ID: 18439103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B.
    McGowan DC; Herschke F; Pauwels F; Stoops B; Smyej I; Last S; Pieters S; Embrechts W; Khamlichi MD; Thoné T; Van Schoubroeck B; Mostmans W; Wuyts D; Verstappen D; Scholliers A; De Pooter D; Dhuyvetter D; Borghys H; Tuefferd M; Arnoult E; Hong J; Fanning G; Bollekens J; Urmaliya V; Teisman A; Horton H; Jonckers THM; Raboisson P
    J Med Chem; 2017 Jul; 60(14):6137-6151. PubMed ID: 28671847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells.
    Kumar A; Zhang J; Yu FS
    Immunology; 2006 Jan; 117(1):11-21. PubMed ID: 16423036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
    J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
    Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.